Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

P OTC 101

Next Previous
Drug Profile

P OTC 101

Alternative Names: P-OTC-101

Latest Information Update: 23 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Poseida Therapeutics
  • Class Gene therapies
  • Mechanism of Action Gene transference; Ornithine carbamoyltransferase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ornithine carbamoyltransferase deficiency disease
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Ornithine carbamoyltransferase deficiency disease

Most Recent Events

  • 10 May 2024 P OTC 101 is still in preclinical studies for Ornithine carbomoyltransferase deficiency disease in USA (parenteral)
  • 31 Jul 2023 P OTC 101 receives Orphan Drug status for Ornithine carbamoyltransferase deficiency disease in USA
  • 18 May 2023 Pharmacodynamics data from preclinical studies in Ornithine carbamoyltransferase deficiency disease released by Poseida Therapeutics

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top